Well, I hear you concerns. I haven't been in this stock as long as you have, but I got in just because of the patents, and the novel way of harvesting cells. It looks to me that they have the solution to the harvesting, with all the news about adipose tissue.
If they report significant revenues, even if it's in a PR, this baby is long gone.
I just think that somehow they missed their target getting LifeStem off the ground. Or, maybe they just were financially strapped for cash. The fourth quarter will give us "some" insite, but they won't report for a while. If you look at the time frame of when De Olden said the revenues would come up to 26 Mil, I think they're about 6 months behind. But, with the thing in Great Britain, and that in Austrailia, it's hard to tell for sure.
As for technicals, I don't think that they work very well, except intra-day, for a penny stock. They "always" seem to work their way downward until the "right" news hits. Candles are they only way to look at these stocks. IMHO
Here's the others in this area I'm watching:
ACTC BCLI CBAI KOOL PLRS VIAC VODG
I'm still interested as to the Institutional holder(s)is.
